alexa Second Primary Ovarian Cancer After First Primary Breast Cancer
ISSN: 2161-0932

Gynecology & Obstetrics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd Annual Conference on Gynecologic Oncology & Preventive Oncology
July 20-21, 2017 Chicago, USA

Hussnain Pervaiz
Grodno State Medical University, Belarus
Posters & Accepted Abstracts: Gynecol Obstet (Sunnyvale)
DOI: 10.4172/2161-0932-C1-016
Abstract
Background: Breast cancer is the most commonly diagnosed cancer after non-melanoma skin cancer and it is the second leading cause of cancer deaths after lung cancer and ovarian cancer is the fifth most deadly cancer in women. Breast and ovarian cancer are features of several hereditary syndromes. Metachronous cancer (multiple primary tumors developing at intervals) will appear more commonly as cancer patients live longer lives. Although ovarian cancer management is well established, less is known of ovarian cancer trends among survivors of breast cancer. Therefore, we examined second primary ovarian cancers after first primary breast cancer during the period of observation in order to ensure that ovarian cancer patients access appropriate treatment to improve the outcome of this disease, accurate analysis of prior cancer disease is essential. Objectives: The relationship between the occurrence of breast and ovarian cancer in patients, their treatment, time span between the occurrence of diseases and stages. Subjects & Methods: The medical records of 68 patients with a history of breast and ovarian cancer, which had been operated on primary cancer between 1994 and 2014 in Grodno Regional Clinical Hospital, were reviewed retrospectively. Results: 68 patients were divided in 3 groups according to first and second diagnose respectively: (1) primary breast cancer and second primary ovarian cancer patients from 35 to 77 years old 47 patients (69%); (2) Primary ovarian cancer and second primary breast cancer from 38 to 69 years old 16 patients (24%); (3) Primary breast cancer and breast cancer + second primary ovarian cancer women from 39 to 47 years old five patients (7%). The mean age for the first diagnose in every group was same that is 50 years. So the median age of primary breast and primary ovarian cancer is the same 50 years. The mean age for the second diagnose was different: For second breast cancer 53 years and for second ovarian cancer was 55 years. We have analyzed the protocols of treatment for 1st diagnosed primary breast cancer. Surgery treatment for primary breast cancer had 48 out of 52 patients. Patients undergo mastectomy with 37 on chemotherapy with 25 on radiotherapy combination. In 3 cases only radiotherapy was administrated. 3 patients disagree from treatment. According to International Federation of Gynecology and Obstetrics (FIGO) stages: Stage-I: 13 patients, Stage-II: 7 patients and Stage-III: 32 patients. Treatment of second ovarian cancer: 42 of 47 patients undergo surgery with 47 having chemotherapy. According to International Federation of Gynecology and Obstetrics (FIGO) stages: Stage-I: 9 patients, Stage-II: 2 patients, stage-III: 32 patients and stage-IV: 4 patients. Conclusion: Patients with lower stage of primary breast cancer further developed the second primary ovarian cancer and they are 69% of all patients with primary metachronous breast and ovarian cancer. Furthermore, the average interval between first and second cancers is substantial and suggests opportunities for interventions (prevention and screening) that might reduce the burden of sequence two and higher cancers.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicals[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords